Groundbreaking Treatment for a Rare Type of Lymphoma

Learn about a significant advancement in lymphoma treatment through this medical lecture where renowned hematologist Dr. Francien Foss from Yale Cancer Center examines the recent FDA approval of a novel therapeutic drug targeting a rare form of lymphoma, offering insights into its development, clinical applications, and potential impact on patient outcomes.